90237-03-9 (法莫替丁亚砜,(Z)-3-(((2-((Diaminomethylene)amino)thiazol-4-yl)methyl)sulfinyl)-N'-sulfamoylpropanimidamide)

CAS号:
90237-03-9
中文名称:
法莫替丁亚砜
英文名称:
(Z)-3-(((2-((Diaminomethylene)amino)thiazol-4-yl)methyl)sulfinyl)-N'-sulfamoylpropanimidamide
分子式:
C8H15N7O3S3
分子量:
353.444795846939

法莫替丁亚砜(90237-03-9)名称与标识符

名称

中文别名:
(R*,R*)-3-氯-alpha-[1-(叔丁基氨基)乙基]苯甲醇;3-[[[2-[(氨基亚胺甲基)氨基]-4-噻唑基]甲基]亚磺酰]-N-(氨基磺酰基)丙脒;3-[2-(二氨基亚甲基氨基)-1,3-噻唑-4-基甲基亚磺酰]-N-氨基磺酰基丙脒法莫替丁亚砜;法莫替丁砜 标准品;法莫替丁亚砜;
英文别名:
3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoylpropanamidine;Famotidine Sulfoxide (25 mg) (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylsulfinyl]-N'-sulfamoylpropanimidamide);3-[[[2-[(AMinoiMinoMethyl)aMino]-4-thiazolyl]Methyl]sulfinyl]-N-(aMinosulfonyl)propaniMidaMide;PropaniMidaMide, 3-[[[2-[(aMinoiMinoMethyl)aMino]-4-thiazolyl]Methyl]sulfinyl]-N-(aMinosulfonyl)-;3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoylpropanamidine Famotidine;[(2-Carbamimidamido-1,3-thiazol-4-yl)methyl][3-imino-3-(sulfamoyl amino)propyl]sulfoniumolate;3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoylpropanamidine Famotidine Sulfoxide;3-[[2-(Diaminomethyleneamino)thiazol-4-yl]methylsulfinyl]-N′-sulfamoylpropanimidamide;3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]sulfinyl]-N-(aminosulfonyl)propanimidamide (ACI);3-(((2-Guanidinothiazol-4-yl)methyl)sulfinyl)-N-sulfamoylpropanimidamide;

标识符

InChIKey:
LAZSSGBZNCVJCB-UHFFFAOYSA-N
Inchi:
1S/C8H15N7O3S3/c9-6(15-21(12,17)18)1-2-20(16)4-5-3-19-8(13-5)14-7(10)11/h3H,1-2,4H2,(H2,9,15)(H2,12,17,18)(H4,10,11,13,14)
SMILES:
O=S(CCC(NS(N)(=O)=O)=N)CC1=CSC(NC(N)=N)=N1

法莫替丁亚砜(90237-03-9)物化性质

实验特性

  • 熔点 : 85-95°C dec.
  • 溶解度 : 微溶 (2.7 g/L) (25 ºC),
  • 密度 : 1.98±0.1 g/cm3 (20 ºC 760 Torr),

法莫替丁亚砜(90237-03-9)安全信息

法莫替丁亚砜(90237-03-9)合成路线

合成路线:1 步
反应条件:
参考文献:
Studies on histamine H2 receptor antagonists. 2. Synthesis and pharmacological activities of N-sulfamoyl and N-sulfonyl amidine derivatives
Yanagisawa, Isao; Hirata, Yasufumi; Ishii, Yoshio, Journal of Medicinal Chemistry, 1987, 30(10), 1787-93
合成路线:1 步
反应条件:
参考文献:
Identification, Synthesis, and Characterization of Unknown Impurity in the Famotidine Powder for Oral Suspension Due to Excipient Interaction by UPLC-MS/MS and NMR
Hotha, Kishore Kumar; Patel, Tejashkumar; Roychowdhury, Swapan; Subramanian, Veerappan, Journal of Liquid Chromatography & Related Technologies, 2015, 38(9), 977-985